GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Devyser Diagnostics AB (OSTO:DVYSR) » Definitions » Beneish M-Score

Devyser Diagnostics AB (OSTO:DVYSR) Beneish M-Score : -1.87 (As of Jun. 19, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Devyser Diagnostics AB Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.87 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Devyser Diagnostics AB's Beneish M-Score or its related term are showing as below:

OSTO:DVYSR' s Beneish M-Score Range Over the Past 10 Years
Min: -2.29   Med: -2.03   Max: -1.87
Current: -1.87

During the past 7 years, the highest Beneish M-Score of Devyser Diagnostics AB was -1.87. The lowest was -2.29. And the median was -2.03.


Devyser Diagnostics AB Beneish M-Score Historical Data

The historical data trend for Devyser Diagnostics AB's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devyser Diagnostics AB Beneish M-Score Chart

Devyser Diagnostics AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - - - -2.14 -2.13

Devyser Diagnostics AB Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.00 -2.01 -2.03 -2.13 -1.87

Competitive Comparison of Devyser Diagnostics AB's Beneish M-Score

For the Diagnostics & Research subindustry, Devyser Diagnostics AB's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Devyser Diagnostics AB's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Devyser Diagnostics AB's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Devyser Diagnostics AB's Beneish M-Score falls into.



Devyser Diagnostics AB Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Devyser Diagnostics AB for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.08+0.528 * 0.9727+0.404 * 1.3933+0.892 * 1.3292+0.115 * 1.6491
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8703+4.679 * 0.042288-0.327 * 1.6091
=-1.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was kr64.6 Mil.
Revenue was 50.7 + 45.4 + 46.7 + 37.7 = kr180.5 Mil.
Gross Profit was 41.9 + 39.9 + 39.6 + 31.5 = kr152.9 Mil.
Total Current Assets was kr306.0 Mil.
Total Assets was kr496.6 Mil.
Property, Plant and Equipment(Net PPE) was kr103.9 Mil.
Depreciation, Depletion and Amortization(DDA) was kr17.0 Mil.
Selling, General, & Admin. Expense(SGA) was kr169.0 Mil.
Total Current Liabilities was kr64.9 Mil.
Long-Term Debt & Capital Lease Obligation was kr52.3 Mil.
Net Income was -12.2 + -13.1 + -6 + -14.6 = kr-45.9 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = kr0.0 Mil.
Cash Flow from Operations was -16.5 + -13.7 + -13.9 + -22.8 = kr-66.9 Mil.
Total Receivables was kr45.0 Mil.
Revenue was 39.5 + 34.2 + 31.2 + 30.9 = kr135.8 Mil.
Gross Profit was 33.7 + 27.2 + 26.3 + 24.7 = kr111.9 Mil.
Total Current Assets was kr394.0 Mil.
Total Assets was kr486.8 Mil.
Property, Plant and Equipment(Net PPE) was kr31.8 Mil.
Depreciation, Depletion and Amortization(DDA) was kr9.6 Mil.
Selling, General, & Admin. Expense(SGA) was kr146.1 Mil.
Total Current Liabilities was kr56.9 Mil.
Long-Term Debt & Capital Lease Obligation was kr14.5 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(64.6 / 180.5) / (45 / 135.8)
=0.357895 / 0.33137
=1.08

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(111.9 / 135.8) / (152.9 / 180.5)
=0.824006 / 0.847091
=0.9727

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (306 + 103.9) / 496.6) / (1 - (394 + 31.8) / 486.8)
=0.174587 / 0.125308
=1.3933

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=180.5 / 135.8
=1.3292

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(9.6 / (9.6 + 31.8)) / (17 / (17 + 103.9))
=0.231884 / 0.140612
=1.6491

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(169 / 180.5) / (146.1 / 135.8)
=0.936288 / 1.075847
=0.8703

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((52.3 + 64.9) / 496.6) / ((14.5 + 56.9) / 486.8)
=0.236005 / 0.146672
=1.6091

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-45.9 - 0 - -66.9) / 496.6
=0.042288

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Devyser Diagnostics AB has a M-score of -1.87 suggests that the company is unlikely to be a manipulator.


Devyser Diagnostics AB Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Devyser Diagnostics AB's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Devyser Diagnostics AB (OSTO:DVYSR) Business Description

Traded in Other Exchanges
N/A
Address
Instrumentvagen 19, Hagersten, SWE, 126 53
Devyser Diagnostics AB is specialized in the development, manufacture and sale of market-leading genetic diagnostic kits.The products are used for complex DNA testing in the hereditary disease, oncology and post-transplantation monitoring fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.

Devyser Diagnostics AB (OSTO:DVYSR) Headlines

No Headlines